Mabvax Therapeutics Holdings Inc (NASDAQ:MBVX) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.34 and traded as low as $0.02. Mabvax Therapeutics shares last traded at $0.02, with a volume of 706 shares changing hands.
The firm’s 50 day moving average price is $0.34.
About Mabvax Therapeutics (NASDAQ:MBVX)
MabVax Therapeutics Holdings, Inc, a clinical stage biopharmaceutical company, discovers, develops, and commercializes proprietary human monoclonal antibody products and vaccines for the treatment of various cancers. The company has a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers.
Featured Story: What is a price target?
Receive News & Ratings for Mabvax Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mabvax Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.